Skip to main content
. 2018 Jun 1;11(6):3010–3018.

Figure 1.

Figure 1

Analysis of unmethylated MMP2 promoter effect on patient survival prognosis. A. Unmethylated genes’ promoter frequency (%) in different grades of glioma. B. Kaplan-Meier survival curves, indicating survival (months) dependency from MMP2 promoter methylation status in all glioma patients; Log-rank test χ 2 = 12.508, df = 1, P < 0.000.